XR Securities »

Celldex Therapeutics shares owned by XR Securities

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by XR Securities from 13F filings

Historical chart of XR Securities investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by XR Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by XR Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $206k 5.2k 39.66

More positions owned by XR Securities

Spdr S&p 500 Etf Etf (SPY)
Invesco Qqq Trust Etf Series Etf (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Facebook Inc cl a Put Option (META)
Amazon (AMZN)
Netflix Call Option (NFLX)
Apple Call Option (AAPL)
Alphabet Inc Class A cs (GOOGL)
Goldman Sachs (GS)
Boeing Company Put Option (BA)
Advanced Micro Devices (AMD)
salesforce Put Option (CRM)
Alphabet Inc Class C cs (GOOG)

View all positions for XR Securities

Top funds holding Celldex Therapeutics

Wellington Management Company
Eventide Asset Management
Vanguard Group
Kynam Capital Management
Point72 Asset Management
Bellevue Group
Marshall Wace
Redmile Group
Octagon Capital Advisors
Commodore Capital
5AM Venture Management
Goldman Sachs Group
Sphera Funds Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Celldex Therapeutics